Share This Page
Suppliers and packagers for TOBRAMYCIN AND DEXAMETHASONE
✉ Email this page to a colleague
TOBRAMYCIN AND DEXAMETHASONE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | TOBRAMYCIN AND DEXAMETHASONE | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 064134 | ANDA | Bausch & Lomb Incorporated | 24208-295-05 | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-05) / 5 mL in 1 BOTTLE, DROPPER | 1999-10-27 |
| Bausch And Lomb | TOBRAMYCIN AND DEXAMETHASONE | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 064134 | ANDA | Bausch & Lomb Incorporated | 24208-295-10 | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-10) / 10 mL in 1 BOTTLE, DROPPER | 1999-10-27 |
| Bausch And Lomb | TOBRAMYCIN AND DEXAMETHASONE | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 064134 | ANDA | Bausch & Lomb Incorporated | 24208-295-25 | 1 BOTTLE, DROPPER in 1 CARTON (24208-295-25) / 2.5 mL in 1 BOTTLE, DROPPER | 1999-10-27 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drugs: Tobramycin and Dexamethasone
Introduction
In the pharmaceutical industry, securing reliable and high-quality suppliers for active pharmaceutical ingredients (APIs) such as Tobramycin and Dexamethasone is crucial for manufacturing efficacy, regulatory compliance, and market stability. These drugs are widely used for antimicrobial and anti-inflammatory purposes, respectively, across various therapeutic indications. This report examines prominent suppliers for Tobramycin and Dexamethasone, analyzing their market presence, geographic distribution, and supply chain reliability to aid stakeholders in strategic sourcing and procurement decisions.
Tobramycin: Overview and Supply Chain Dynamics
Tobramycin is an aminoglycoside antibiotic primarily used to treat serious bacterial infections, especially in ocular, respiratory, and systemic applications. Its complex manufacturing process demands stringent quality control, which influences supplier selection.
Key Suppliers for Tobramycin
1. Hikma Pharmaceuticals
A leading global generics manufacturer based in Jordan, Hikma is a major supplier of Tobramycin in various formulations, including injectable and ophthalmic solutions. Known for robust quality standards, Hikma exports to over 50 countries and maintains WHO-GMP certification, making it a preferred supplier for multinational pharmaceutical companies.
2. Sandoz (Novartis)
Sandoz, a division of Novartis, offers Tobramycin as part of its comprehensive antimicrobial portfolio. Sandoz's global manufacturing footprint in Europe and North America ensures high-quality APIs, with adherence to strict regulatory standards, including EMA and FDA approvals.
3. Zhejiang Hisun Pharmaceutical Co. Ltd.
A prominent Chinese manufacturer with extensive API and finished dosage manufacturing capabilities. Hisun supplies Tobramycin to Asian markets and increasingly to international clients, benefiting from competitive pricing and scalable production capacity.
4. Aurobindo Pharma
Based in India, Aurobindo produces Tobramycin formulations and APIs supplied globally. The company’s facilities are cGMP-compliant, and its strategic positioning in India allows cost-effective and reliable supply chains for generic drugs.
5. Jiangsu Hengrui Medicine Co., Ltd.
Another major Chinese API producer, Hengrui offers high-purity Tobramycin APIs for export. Its investments in R&D and quality assurance position it as a competitive supplier in the Asian and international markets.
Dexamethasone: Overview and Market Participants
Dexamethasone is a potent synthetic corticosteroid used predominantly for its anti-inflammatory and immunosuppressant properties. Its broad therapeutic application and high demand have resulted in a diverse and extensive supply chain.
Leading Suppliers for Dexamethasone
1. Pfizer Inc.
As a pioneer in corticosteroid manufacturing, Pfizer supplies Dexamethasone in various formulations, including oral tablets, injections, and topical applications. Pfizer's global scale ensures consistent quality and supply reliability, supported by extensive R&D and manufacturing infrastructure.
2. Mylan (now part of Viatris)
A major producer of generic pharmaceuticals, Mylan (Viatris) provides Dexamethasone APIs and finished dosage forms worldwide. The company maintains ISO-certified manufacturing sites across India, the EU, and the US, offering robust supply chains.
3. Sun Pharmaceutical Industries Ltd.
An Indian pharmaceutical giant, Sun Pharma produces Dexamethasone APIs and formulations with extensive international distribution. Their facilities are deemed cGMP-compliant, and they serve as significant suppliers for both domestic and export markets.
4. Dr. Reddy’s Laboratories
A key Indian pharmaceutical firm, Reddy’s supplies Dexamethasone API and dosages, emphasizing affordability and high quality. Their manufacturing units adhere to WHO-GMP guidelines, making them a dependable source for generics.
5. Zhejiang Hisun Pharmaceutical Co. Ltd.
In addition to Tobramycin, Hisun also manufactures Dexamethasone APIs. Derived from Chinese manufacturing infrastructure, they serve both Asian and international markets with competitive pricing.
Strategic Sourcing Considerations
Regulatory Compliance
Suppliers must meet international standards such as FDA, EMA, and WHO-GMP certifications. Brands sourcing these APIs for regulated markets should prioritize suppliers with proven compliance records and transparent quality documentation.
Geographical Diversification
Dependence on suppliers from China and India is common due to cost advantages and manufacturing capacity. However, diversifying sources across regions reduces supply chain risks, especially under geopolitical or diplomatic uncertainties.
Supply Chain Reliability
Due to COVID-19 disruptions, consistency in supply has become a critical factor. Leading companies like Pfizer and Novartis maintain high inventory levels and contingency plans, whereas smaller or regional suppliers might be more vulnerable to production delays.
Pricing and Contract Terms
Pricing competitiveness varies significantly, with Chinese suppliers typically offering lower costs. Long-term contractual agreements and quality assurance clauses help mitigate risks of supply interruptions or quality issues.
Market Outlook and Emerging Trends
The global demand for Tobramycin and Dexamethasone remains robust, driven by escalating bacterial infections and inflammatory conditions. The increasing adoption of biosimilars and generics, along with capacity expansions in India and China, is expected to stabilize or reduce API costs.
Emerging trends include supply chain digitalization, quality assurance enhancements, and sustainability initiatives. Suppliers investing in advanced manufacturing processes and environmentally friendly practices are gaining competitive advantage.
Conclusion
Securing reliable suppliers for Tobramycin and Dexamethasone necessitates a comprehensive review of quality standards, geopolitical considerations, and supply chain resilience. Major multinational corporations like Pfizer, Sandoz, and Viatris lead the market for Dexamethasone, while Hikma, Aurobindo, and Chinese manufacturers dominate Tobramycin supply chains. Strategic diversification, rigorous quality assurance, and adherence to regulatory standards are paramount for pharmaceutical companies seeking to mitigate risks and ensure uninterrupted production.
Key Takeaways
- Major suppliers for Tobramycin include Hikma, Zhejiang Hisun, and Aurobindo, with Chinese and Indian manufacturers offering cost-effective options.
- Dexamethasone suppliers such as Pfizer, Viatris, and Sun Pharma maintain high global standards, ensuring quality and regulatory compliance.
- Diversifying supplier bases across regions reduces supply chain risks amid geopolitical and pandemic-related disruptions.
- Strategic sourcing should account for regulator certification, production capacity, and long-term supply stability.
- Emerging trends like digital supply chain management and sustainability practices are influencing supplier selection criteria.
FAQs
1. How can pharmaceutical companies verify the quality of Tobramycin and Dexamethasone suppliers?
They should verify GMP, ISO, and WHO certifications, request batch testing reports, and conduct site audits to ensure compliance with quality standards.
2. Are Chinese and Indian manufacturers reliable suppliers for these APIs?
Yes, many Chinese and Indian manufacturers have achieved WHO-GMP and other international certifications, offering reliable supply chains when appropriately vetted.
3. What risks are associated with over-reliance on specific geographic regions?
Risks include geopolitical tensions, supply chain disruptions, and regulatory changes that can impact manufacturing continuity.
4. How do regulatory approvals influence supplier selection?
Suppliers with approved manufacturing facilities by FDA, EMA, or other regulators are preferred, as they meet strict quality and safety standards required in major markets.
5. Are biosimilars impacting the supply chain for these drugs?
While biosimilars target biologics, generics of small molecules like Tobramycin and Dexamethasone continue to dominate supply chains due to cost advantages. However, biosimilar development is increasingly influencing the broader pharmaceutical landscape.
Sources:
[1] Pharma Intelligence, “Global API Suppliers and Market Analysis,” 2022.
[2] World Health Organization, “WHO Good Manufacturing Practices (GMP) Certification Database,” 2023.
[3] Industry reports, “The Future of Antibiotics and Corticosteroids Market,” 2023.
[4] Company disclosures and official websites.
(Note: The specific citations are illustrative; actual sources should be used based on up-to-date industry data.)
More… ↓
